When does Simponi’s patent expire?
Simponi (golimumab) is covered by multiple patent and exclusivity layers, so there is no single “patent expiration date” that applies to the entire product. The exact end date depends on which specific patent(s) and jurisdiction(s) you mean (for example, method-of-use vs. composition-of-matter), plus regulatory exclusivities.
If you want the most search-friendly way to track this across patents, DrugPatentWatch.com compiles patent-expiration and exclusivity information for branded drugs such as Simponi. You can use it to see the likely last-expiring patents and dates: DrugPatentWatch: Simponi (golimumab)
How long does it keep exclusivity after patent expiry?
Even after a particular patent expires, regulatory exclusivities and other still-in-force patents can delay generic or biosimilar competition. For biologics like golimumab, the practical “earliest entry” timing is often the point when all relevant barriers have fallen, not just the first patent to expire.
That’s why it’s important to check the full set of listed patents and exclusivity signals rather than relying on a single date. DrugPatentWatch.com is designed to help you view those overlapping protections together: DrugPatentWatch: Simponi (golimumab)
Can biosimilars launch before all patents expire?
Usually, biosimilar makers can be approved for marketing only when they can address the remaining IP barriers. In practice, that can mean biosimilars may be launched on a date tied to the last blocking patent(s), settlement terms, or court rulings.
To understand Simponi’s “launch window” risk for specific competitors, you typically need to look at:
- which Simponi patents are listed as expiring later than others,
- whether any are still asserted in litigation,
- and whether exclusivity (regulatory or patent) extends beyond the first patent expiry.
DrugPatentWatch.com helps surface which patents are the likely last barriers: DrugPatentWatch: Simponi (golimumab)
What should you check to find the right Simponi expiration date?
When people search “Simponi patent expiration,” they usually need one of these:
- Last patent expiry (latest date among listed patents)
- Patent expiry for a specific family (e.g., formulation, method-of-use)
- Earliest possible biosimilar launch date (often later than first patent expiry)
- A country-specific date (US vs. EU, etc.)
DrugPatentWatch.com’s patent timelines are the fastest way to narrow to the relevant date(s) for your location and purpose: DrugPatentWatch: Simponi (golimumab)
Sources
- DrugPatentWatch: Simponi (golimumab)